Physicians' Academy for Cardiovascular Education

Increased risk of acute MI on DOAC vs. VKA in real world AF patients

Risk of myocardial infarction in patients with atrial fibrillation using vitamin K ant agonists, aspirin or direct acting oral anticoagulants

Literature - Stolk LM, De Vries F, Ebbelaar C et al., - Br J Clin P harmacol 2017. DOI: 10.1111/bcp.13264

Main results

Conclusion

This analysis shows that in real-world patients with AF who are currently treated with DOACs or aspirin, the risk of AMI was doubled as compared with current users of VKA. After stratifying for gender, a significantly increased risk was only seen for users of aspirin. When stratifying for stroke risk based on CHA2DS2-VASc score, the risk of AMI remained significantly increased in high and medium risk patients on DOAC and aspirin, as compared with current users of VKAs.

References

Show references

Find this article online at Br J Clin Pharmacol

Share this page with your colleagues and friends: